ATE91901T1 - Vehikel zur verabreichung von interferon. - Google Patents

Vehikel zur verabreichung von interferon.

Info

Publication number
ATE91901T1
ATE91901T1 AT85400189T AT85400189T ATE91901T1 AT E91901 T1 ATE91901 T1 AT E91901T1 AT 85400189 T AT85400189 T AT 85400189T AT 85400189 T AT85400189 T AT 85400189T AT E91901 T1 ATE91901 T1 AT E91901T1
Authority
AT
Austria
Prior art keywords
interferon
interferons
effective amount
vehicle
vehicle base
Prior art date
Application number
AT85400189T
Other languages
English (en)
Inventor
Leonard F Estis
Sean A Evans
Douglas Testa
Original Assignee
Interferon Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interferon Sciences Inc filed Critical Interferon Sciences Inc
Application granted granted Critical
Publication of ATE91901T1 publication Critical patent/ATE91901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT85400189T 1984-02-07 1985-02-05 Vehikel zur verabreichung von interferon. ATE91901T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/577,911 US4680175A (en) 1984-02-07 1984-02-07 Interferon administration vehicles
EP85400189A EP0152345B1 (de) 1984-02-07 1985-02-05 Vehikel zur Verabreichung von Interferon

Publications (1)

Publication Number Publication Date
ATE91901T1 true ATE91901T1 (de) 1993-08-15

Family

ID=24310647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85400189T ATE91901T1 (de) 1984-02-07 1985-02-05 Vehikel zur verabreichung von interferon.

Country Status (6)

Country Link
US (2) US4680175A (de)
EP (1) EP0152345B1 (de)
JP (1) JPH075479B2 (de)
AT (1) ATE91901T1 (de)
CA (1) CA1254832A (de)
DE (1) DE3587479T2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
DE3603444A1 (de) * 1986-02-05 1987-08-06 Thomae Gmbh Dr K Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha
DE3621828A1 (de) * 1986-06-28 1988-01-14 Biotest Pharma Gmbh Stabilisierung eines fuer therapeutische zwecke, insbesondere beim menschen, bestimmten interleukin-2-praeparates sowie dieses praeparat enthaltende stabilisierte waessrige loesung oder feststoff
DE3628468A1 (de) * 1986-08-21 1988-03-03 Thomae Gmbh Dr K Neue applikationsformen fuer (alpha)-interferone
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
CA1294215C (en) * 1986-10-27 1992-01-14 Ze'ev Shaked Pharmaceutical compositions of recombinant beta-interferon and formulation processes
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5366081A (en) 1987-08-26 1994-11-22 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5306289A (en) * 1987-08-26 1994-04-26 United States Surgical Corporation Braided suture of improved characteristics
US5472702A (en) * 1987-08-26 1995-12-05 United States Surgical Corporation Sterilization of growth factors
US5226912A (en) 1987-08-26 1993-07-13 United States Surgical Corporation Combined surgical needle-braided suture device
US5222978A (en) 1987-08-26 1993-06-29 United States Surgical Corporation Packaged synthetic absorbable surgical elements
US5266310A (en) * 1987-09-17 1993-11-30 Boehringer Ingelheim International Gmbh Stabilization of therapeutically active proteins in pharmaceutical preparations
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
WO1989005149A1 (en) * 1987-12-03 1989-06-15 The Liposome Company, Inc. Methyl cellulose pharmaceutical composition
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
WO1989010756A1 (fr) * 1988-05-06 1989-11-16 Toray Industries, Inc. COMPOSITION D'INTERFERON beta STABLE
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
SE462364B (sv) * 1988-09-30 1990-06-18 Goeran Hansson Anvaendning av gamma-interferon foer beredning av ett preparat foer behandling av vaskulaer stenos
US5246104A (en) * 1989-08-01 1993-09-21 United States Surgical Corporation Molded suture retainer
US5359831A (en) 1989-08-01 1994-11-01 United States Surgical Corporation Molded suture retainer
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
EP0625991B1 (de) * 1992-02-10 1999-04-28 Interferon Sciences, Inc. Verbesserte alpha-interferon-zusammensetzung und verfahren zu ihrer herstellung aus leukocyten des menschlichen peripheren blute
US5676942A (en) * 1992-02-10 1997-10-14 Interferon Sciences, Inc. Composition containing human alpha interferon species proteins and method for use thereof
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
JPH0717790U (ja) * 1993-07-15 1995-03-31 東洋ケミカル株式会社 フロッピーディスク収納ケース
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
FI106465B (fi) * 1998-06-10 2001-02-15 Suomen Punainen Risti Veripalv Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi
FI105319B (fi) * 1998-06-10 2000-07-31 Suomen Punainen Risti Veripalv Menetelmä multikomponentti-alfa-interferonin valmistamiseksi
RU2165768C2 (ru) * 1999-06-18 2001-04-27 Государственное предприятие НПО "ВИРИОН" Препарат "интеровир" для лечения и профилактики вирусных заболеваний
JP2006508971A (ja) * 2002-11-20 2006-03-16 アライバ−プロメティック インコーポレイティド プロテアーゼ阻害剤を使用して炎症性疾患を治療する組成物及び方法
EP1793860B1 (de) * 2004-07-15 2009-08-05 GynaecologIQ B.V. Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
DE102006039148A1 (de) * 2006-08-18 2008-02-21 Virologik Gmbh Innovationszentrum Medizintechnik Und Pharma Verwendung von Chloro- und Fluoromethylketon-Derivaten in der anti-viralen Therapie
NL2003660C2 (en) 2009-10-16 2011-04-19 Giskit B V Composition and method for medical imaging of body cavities.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584686B2 (ja) * 1977-09-09 1983-01-27 ゼリア新薬工業株式会社 安定な経口用ウロキナ−ゼ製剤
JPS55102519A (en) * 1979-01-31 1980-08-05 Green Cross Corp:The Stabilization of interferon
JPS57179122A (en) * 1981-04-28 1982-11-04 Isamu Horikoshi Blood coagulation factor ix preparation for oral administration
US4348384A (en) * 1980-10-17 1982-09-07 Dainippon Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration containing coagulation factor VIII or IX
WO1983001198A1 (en) * 1981-10-08 1983-04-14 Kurt Frimann Berg Method and composition for treating a patient suffering from interferon-susceptible disorder
US4507281A (en) * 1981-10-13 1985-03-26 Exovir, Inc. Interferon-containing compositions
EP0080032A3 (de) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmazeutische Zubereitung für die Behandlung von herpetischen Verletzungen
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels

Also Published As

Publication number Publication date
JPS60188328A (ja) 1985-09-25
JPH075479B2 (ja) 1995-01-25
US4680175A (en) 1987-07-14
DE3587479D1 (de) 1993-09-02
DE3587479T2 (de) 1993-12-09
EP0152345A3 (en) 1987-09-23
EP0152345B1 (de) 1993-07-28
EP0152345A2 (de) 1985-08-21
CA1254832A (en) 1989-05-30
US4911908A (en) 1990-03-27

Similar Documents

Publication Publication Date Title
ATE91901T1 (de) Vehikel zur verabreichung von interferon.
UA29406C2 (uk) Складні ефіри трициклічних аміноспиртів
MX163955B (es) Composicion farmaceutica de dihidrocodeina e ibuprofen
ATE53762T1 (de) Fluessige diclofenac-zubereitungen.
ATE190838T1 (de) Injizierbare arzneizubereitungen enthaltend taxanderivate
EG18379A (en) Novel pharmacological compounds
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
UA26303A1 (uk) Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість
MY101791A (en) New benzimidazole derivatives
DE69034070D1 (de) Racemisches Huperzin A
PT964687E (pt) Composicoes farmaceuticas com actividade antimicrobiana
NO994640D0 (no) Hostestillende midler
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ATE63750T1 (de) Peptid, dessen herstellung und benutzung.
ATE65912T1 (de) Arzneimittelzusammensetzungen ermaessigter toxizitaet.
DK1032378T3 (da) Anvendelse af en blanding af en diol og en alfa-hydroxysyre til behandling af hyperkeratosiske hudsygdomme
ATE70453T1 (de) Verwendung von interleukin-1-proteinen gegen arthritis.
ZA935046B (en) Use of lysozyme dimer and compositions containing the same
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью
IE800724L (en) Analgesic and myotonolytic preparations
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
EP0314984A3 (de) Verwendung von 2-Pyrimidinyl-1-piperazin-Derivaten
GB8327598D0 (en) Pharmacologically active diarylindane-13-diones
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
GB1051686A (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee